Literature DB >> 20619733

Trends in hospitalised sport/leisure injuries in New South Wales, Australia--implications for the targetting of population-focussed preventive sports medicine efforts.

Caroline F Finch1, Rebecca Mitchell, Soufiane Boufous.   

Abstract

Sport/leisure injuries are a population health issue in Australia. Over 2003-2004 to 2007-2008, the rate of sport/leisure injury NSW hospitalisations was 195.5/100,000 residents. Males and children/young people had consistently highest rates of hospitalisation. There was no significant decline in rates over this period and no change in the profiles of the types of sport/leisure injuries. The extent to which effective preventive programs have been developed and implemented needs to be determined as current programs do not seem to be impacting on hospitalisation rates. Medical/health promotion agencies and sports bodies need to jointly formulate and implement policies to reduce sport/leisure injuries. This is one of the most significant challenges facing sports medicine professionals today.
Copyright © 2010 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20619733     DOI: 10.1016/j.jsams.2010.03.009

Source DB:  PubMed          Journal:  J Sci Med Sport        ISSN: 1878-1861            Impact factor:   4.319


  2 in total

1.  Prevalence of adolescent physical activity-related injuries in sports, leisure time, and school: the National Physical Activity Behaviour Study for children and Adolescents.

Authors:  Anu M Räisänen; Sami Kokko; Kati Pasanen; Mari Leppänen; Arja Rimpelä; Jari Villberg; Jari Parkkari
Journal:  BMC Musculoskelet Disord       Date:  2018-02-15       Impact factor: 2.362

2.  Time to add a new priority target for child injury prevention? The case for an excess burden associated with sport and exercise injury: population-based study.

Authors:  Caroline F Finch; Anna Wong Shee; Angela Clapperton
Journal:  BMJ Open       Date:  2014-07-02       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.